Dominik Naczynski

Dominik Naczynski, Ph.D., joined Boxer Capital, LLC in 2014. As Senior Vice President, Dr. Naczynski is responsible for conducting due diligence of public and private investments in healthcare. In his role, he also serves as a Member of the Board of Directors for Cedilla Therapeutics, Inc.

Dr. Naczynski received a Bachelor of Arts degree in Chemical Engineering from Cornell University and a Ph.D. in Chemical Engineering from Rutgers University as an NIH-sponsored Biotechnology Fellow. He completed his postdoctoral training in radiation oncology at the Stanford University School of Medicine and was a graduate of the Ignite Program within the Stanford Graduate School of Business. He has authored and been the recipient of research grants from the National Institutes of Health, National Cancer Institute, Department of Defense, and other organizations. He has also published in leading scientific journals, including Nature Communications, and listed as a co-inventor on several medical device patents.